ArticleThe World Allergy Organization journal2026

Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study.

Giorgio Walter Canonica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.